You are here

cystic fibrosis

AmpliPhi Presents Case Study of Bacteriophage Used to Treat Drug Resistant Infection in Cystic Fibrosis Patient

AmpliPhi Presents Case Study of Bacteriophage Used to Treat Drug Resistant Infection in Cystic Fibrosis Patient

CP Wire

Ampliphi Biosciences

cystic fibrosis

Flag link:

FDA relaxes clinical hold on Translate Bio’s cystic fibrosis drug

FDA relaxes clinical hold on Translate Bio’s cystic fibrosis drug

Fierce Biotech

clinical trials

cystic fibrosis

Flag link:

Proteostasis Therapeutics' Abrupt Turn-Around on Share Offering

Proteostasis Therapeutics' Abrupt Turn-Around on Share Offering

CP Wire

Proteostasis Therapeutics

cystic fibrosis

clinical trials

Flag link:

Vertex cancels plans for CF triple combo testing in France, citing failed Orkambi negotiations

Vertex cancels plans for CF triple combo testing in France, citing failed Orkambi negotiations

Fierce Pharma

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

New approval helps Vertex's 'cleanest growth story in biotech'

New approval helps Vertex's 'cleanest growth story in biotech'

Biopharma Dive

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex Picks 'Impressive' Cystic Fibrosis Drugs To Aim For A Multibillion-Dollar Market

Vertex Picks 'Impressive' Cystic Fibrosis Drugs To Aim For A Multibillion-Dollar Market

Forbes

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Galapagos' progress won't rattle CF markets, analysts say

Galapagos' progress won't rattle CF markets, analysts say

Biopharma Dive

cystic fibrosis

Flag link:

Biotech of the Year: Vertex Pharmaceuticals

Biotech of the Year: Vertex Pharmaceuticals

BioPharma Dive

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Galapagos continues in Vertex's shadow

Galapagos continues in Vertex's shadow

BioPharma Dive

cystic fibrosis

Flag link:

Vertex Pops As Analyst Questions Whether Rival Has 'Viable Drug'

Vertex Pops As Analyst Questions Whether Rival Has 'Viable Drug'

Investors Business Daily

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex Pharmaceuticals: The Gilead Sciences of Cystic Fibrosis?

Vertex Pharmaceuticals: The Gilead Sciences of Cystic Fibrosis?

Motley Fool

Vertex Pharmaceuticals

cystic fibrosis

Gilead Sciences

tezecaftor/ivacaftor

Flag link:

Vertex Plans To Eradicate Cystic Fibrosis, And Go From There

Vertex Plans To Eradicate Cystic Fibrosis, And Go From There

Investors Business Daily

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex's Cystic Fibrosis Combo Gets Priority Review in U.S.

Vertex's Cystic Fibrosis Combo Gets Priority Review in U.S.

Yahoo/Zacks.com

Vertex Pharmaceuticals

cystic fibrosis

priority review

tezacaftor/ivacaftor

Flag link:

Vertex wins new Kalydeco approval, ups sales forecast

Vertex wins new Kalydeco approval, ups sales forecast

BioPharma Dive

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex set up for CF monopoly due to data, contracts

Vertex set up for CF monopoly due to data, contracts

BioPharma Dive

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Biotech Stocks on Fire After Vertex News

Biotech Stocks on Fire After Vertex News

Investopedia

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

'Just What We Dreamed.' New Vertex Drugs Show Dramatic Benefit Against Cystic Fibrosis

'Just What We Dreamed.' New Vertex Drugs Show Dramatic Benefit Against Cystic Fibrosis

Forbes

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Is Vertex Pharmaceuticals Running Out of Steam or Taking a Breather?

Is Vertex Pharmaceuticals Running Out of Steam or Taking a Breather?

Motley Fool

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Inside Vertex Pharmaceuticals’ Clinical Pipeline

Inside Vertex Pharmaceuticals’ Clinical Pipeline

Market Realist

Vertex Pharmaceuticals

Tezacaftor-Ivacaftor

cystic fibrosis

Flag link:

FDA Details How Kalydeco's Indication Expanded Without New Clinical Data

FDA Details How Kalydeco's Indication Expanded Without New Clinical Data

RAPS.org

cystic fibrosis

Flag link:

Pages